Back to BAKER BROS. ADVISORS LP

PRLD
Showing 8 of 23 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in PRELUDE THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 10.1M shares of PRLD (PRELUDE THERAPEUTICS INC), worth $34.6M as of 2026-Q1. PRLD represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$34.6M

Current Shares

10.1M

Total Value Change

-$3.9M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
10.1M
0.0%
$34.6M0.2%$2.63
0
2025-Q4
Unchanged
10.1M
0.0%
$29.4M0.2%$2.84
0
2025-Q3
Unchanged
10.1M
0.0%
$14.6M0.1%$1.37
0
2025-Q2
Unchanged
10.1M
0.0%
$8.2M0.1%$0.79
0
2025-Q1
Unchanged
10.1M
0.0%
$7.8M0.1%$0.80
0
2024-Q4
Unchanged
10.1M
0.0%
$12.9M0.1%$1.21
0
2024-Q3
Unchanged
10.1M
0.0%
$21M0.2%$2.12
0
2024-Q2
Unchanged
10.1M
0.0%
$38.6M0.5%$3.81
0

Other major holders of PRLD: HHLR ADVISORS, LTD., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used